ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine; riboflavin; thiamine; tocopherol acetate; vitamin a; vitamin k · Sandoz Canada Inc · NDA 021265
Infuvite Pediatric
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- First generic approved · ANDA 210671, Apotex · 021265-001Approved 21 Apr 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 210671, Apotex · 021265-001Approved 21 Apr 2026Detected 25 Oct 2026Historical import
- First generic approved · ANDA 210456, Apotex · 021265-001Approved 21 Apr 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 210456, Apotex · 021265-001Approved 21 Apr 2026Detected 25 Oct 2026Historical import
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021265 · 001 · RLD | injectable, intravenous | 80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL | open |